You are here

Valeant selling US$2.1b in assets to pay down debt

Wednesday, January 11, 2017 - 05:50


VALEANT Pharmaceuticals International Inc, the embattled Canadian drugmaker, has agreed to sell about US$2.1 billion in assets to get cash to streamline its businesses and begin easing its debt burden.

L'Oreal SA will pay Valeant US$1.3 billion for three skincare brands, the

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom